FarmaMondo approves Ellanse in Taiwan

FarmaMondo announces the approval of Ellanse, an innovative product in the esthetic segment, by the Taiwan local regulatory body – TFDA – as a medical device class II.

The product was licensed to FarmaMondo on an exclusive basis for certain markets and has been approved as a novel therapy with the local authority. FarmaMondo intends to commercialize the product into the local market through a partner network in the territory.